PT807691E - Metodo para a pesquisa quanto a presenca de um defeito genetico associado a trombose e/ou fraca resposta anticoagulante a proteina c activada - Google Patents

Metodo para a pesquisa quanto a presenca de um defeito genetico associado a trombose e/ou fraca resposta anticoagulante a proteina c activada

Info

Publication number
PT807691E
PT807691E PT97201766T PT97201766T PT807691E PT 807691 E PT807691 E PT 807691E PT 97201766 T PT97201766 T PT 97201766T PT 97201766 T PT97201766 T PT 97201766T PT 807691 E PT807691 E PT 807691E
Authority
PT
Portugal
Prior art keywords
thrombosis
protein
activated
genetic defect
research
Prior art date
Application number
PT97201766T
Other languages
English (en)
Inventor
Rogier Maria Bertina
Pieter Hendrik Retsma
Original Assignee
Univ Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8216642&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT807691(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Leiden filed Critical Univ Leiden
Publication of PT807691E publication Critical patent/PT807691E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PT97201766T 1994-02-14 1995-02-14 Metodo para a pesquisa quanto a presenca de um defeito genetico associado a trombose e/ou fraca resposta anticoagulante a proteina c activada PT807691E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94200377 1994-02-14

Publications (1)

Publication Number Publication Date
PT807691E true PT807691E (pt) 2002-04-29

Family

ID=8216642

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97201766T PT807691E (pt) 1994-02-14 1995-02-14 Metodo para a pesquisa quanto a presenca de um defeito genetico associado a trombose e/ou fraca resposta anticoagulante a proteina c activada

Country Status (14)

Country Link
US (3) US6518016B1 (pt)
EP (2) EP0696325B1 (pt)
JP (2) JP3163105B2 (pt)
KR (1) KR100384251B1 (pt)
AT (2) ATE166110T1 (pt)
AU (1) AU690644B2 (pt)
CA (1) CA2159907C (pt)
DE (3) DE69523179T2 (pt)
DK (2) DK0696325T3 (pt)
ES (2) ES2166948T3 (pt)
FI (1) FI117977B (pt)
GR (2) GR960300034T1 (pt)
PT (1) PT807691E (pt)
WO (1) WO1995021938A1 (pt)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935522A (en) * 1990-06-04 1999-08-10 University Of Utah Research Foundation On-line DNA analysis system with rapid thermal cycling
WO1996030546A1 (en) * 1995-03-24 1996-10-03 The Scripps Research Institute Methods for identifying a factor v gene mutation
WO1997007240A1 (en) * 1995-08-21 1997-02-27 Akzo Nobel N.V. T-pa polymorphism and use thereof in diagnosis of risk of thrombus associated disease
US20030143759A1 (en) * 1995-10-20 2003-07-31 Bjorn Dahlback Assays for determining anticoagulant cofactor activity
US5766869A (en) * 1995-11-30 1998-06-16 Ahs Hospital Corp. Factor V ratio blood test for susceptibility to thromboembolism
GB9604267D0 (en) * 1996-02-29 1996-05-01 Royal Infirmary Of Edinburgh N Mutation assay
US6379975B1 (en) 1996-11-27 2002-04-30 T.A.C. Thrombosis And Coagulation Aktiebolag Methods and reagents for determining protein S
AT404993B (de) * 1997-01-13 1999-04-26 Immuno Ag Verfahren zur bestimmung eines proteins mit einer mutation
US6451526B1 (en) * 1998-01-20 2002-09-17 Mayo Foundation For Medical Education And Research Simplified mutation detection
DE19802377A1 (de) 1998-01-22 1999-08-19 Max Planck Gesellschaft Verwendung von Inhibitoren für die Behandlung von RTK-Überfunktions-bedingten Störungen, insbesondere von Krebs
US6270974B1 (en) 1998-03-13 2001-08-07 Promega Corporation Exogenous nucleic acid detection
US6335162B1 (en) 1998-03-13 2002-01-01 Promega Corporation Nucleic acid detection
US6312902B1 (en) 1998-03-13 2001-11-06 Promega Corporation Nucleic acid detection
US6268146B1 (en) 1998-03-13 2001-07-31 Promega Corporation Analytical methods and materials for nucleic acid detection
US6703211B1 (en) 1998-03-13 2004-03-09 Promega Corporation Cellular detection by providing high energy phosphate donor other than ADP to produce ATP
US6235480B1 (en) 1998-03-13 2001-05-22 Promega Corporation Detection of nucleic acid hybrids
US6391551B1 (en) 1998-03-13 2002-05-21 Promega Corporation Detection of nucleic acid hybrids
US6270973B1 (en) 1998-03-13 2001-08-07 Promega Corporation Multiplex method for nucleic acid detection
US7090975B2 (en) 1998-03-13 2006-08-15 Promega Corporation Pyrophosphorolysis and incorporation of nucleotide method for nucleic acid detection
DE19840897A1 (de) * 1998-09-08 2000-03-09 Dirk Happich Faktor V-Leiden-Test
US6703228B1 (en) * 1998-09-25 2004-03-09 Massachusetts Institute Of Technology Methods and products related to genotyping and DNA analysis
EP1001037A3 (en) * 1998-09-28 2003-10-01 Whitehead Institute For Biomedical Research Pre-selection and isolation of single nucleotide polymorphisms
DE19848665A1 (de) * 1998-10-22 2000-04-27 Bayer Ag Ein automatisierbarer Schnelltest zum direkten Nachweis der APC Resistenz Mutation mit spezifischen Primern und Probes
AU774085B2 (en) * 1999-02-18 2004-06-17 Promega Corporation Multiplex method for nucleic acid detection
US6238868B1 (en) * 1999-04-12 2001-05-29 Nanogen/Becton Dickinson Partnership Multiplex amplification and separation of nucleic acid sequences using ligation-dependant strand displacement amplification and bioelectronic chip technology
JP2002541475A (ja) * 1999-04-12 2002-12-03 ナノゲン／ベクトン・ディッキンソン・パートナーシップ 鎖置換増幅およびバイオエレクトロニック・マイクロチップ技術を用いる核酸配列の増幅および分離
US6582920B2 (en) * 2000-09-01 2003-06-24 Gen-Probe Incorporated Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
WO2002046476A2 (en) * 2000-10-27 2002-06-13 Abbott Laboratories Genotyping using partially-complementary probes
US6855509B2 (en) 2000-12-19 2005-02-15 Instrumentation Laboratory Company Protein S functional assay and kit therefor
WO2003076869A1 (en) * 2002-03-13 2003-09-18 Borealis Technology Oy Apparatus for inspecting deformation of pipes
US20030177850A1 (en) * 2002-03-19 2003-09-25 The Washington Post Company System and method for verifying the roll roundness of rolls of paper used for newspapers
US20050026168A1 (en) * 2002-12-13 2005-02-03 Genesis Group Inc. Method for the detection of risk factors associated with myocardial infarction
US20050032066A1 (en) * 2003-08-04 2005-02-10 Heng Chew Kiat Method for assessing risk of diseases with multiple contributing factors
FR2866349B1 (fr) * 2004-02-12 2008-05-16 Biomerieux Sa Procede de diagnostic/pronostic d'une thrombose
WO2006008267A2 (en) * 2004-07-16 2006-01-26 Novo Nordisk Health Care Ag Methods for optimizing forming viiia-based hemostatic treatment
EP1623996A1 (en) * 2004-08-06 2006-02-08 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Improved method of selecting a desired protein from a library
WO2006027111A1 (en) * 2004-09-06 2006-03-16 Zlb Behring Gmbh Modified coagulation factor viii with enhanced stability
KR100655658B1 (ko) * 2005-07-26 2006-12-08 삼성전자주식회사 게이트 전극 구조물과 그 제조 방법 및 이를 갖는 반도체트랜지스터와 그 제조 방법
EP1982008A4 (en) * 2006-01-12 2009-09-30 Univ British Columbia POLYMORPHISMS ASSOCIATED WITH THE PROTEIN C PATHWAY AS PREDICTORS OF THE RESPONSE TO THE ADMINISTRATION OF ACTIVATED PROTEIN C OR A PROTEIN-C-SIMILAR COMPOUND
JP2009527487A (ja) * 2006-02-16 2009-07-30 ザ ハーシー カンパニー ココア製品及び心血管状態を無糖ココアで処置する方法
WO2008020090A1 (es) * 2006-08-18 2008-02-21 Laboratorios Indas, S.A. Método y kit para diagnosticar el riesgo de desarrollar una enfermedad trombótica venosa
US20090292213A1 (en) * 2008-05-21 2009-11-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US20090287120A1 (en) * 2007-12-18 2009-11-19 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US20090163856A1 (en) * 2007-12-19 2009-06-25 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Treatment indications informed by a prior implant information
US9717896B2 (en) 2007-12-18 2017-08-01 Gearbox, Llc Treatment indications informed by a priori implant information
US20100036263A1 (en) * 2008-08-07 2010-02-11 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US8636670B2 (en) * 2008-05-13 2014-01-28 The Invention Science Fund I, Llc Circulatory monitoring systems and methods
US20090292214A1 (en) * 2008-05-22 2009-11-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
PT2535424E (pt) 2011-06-16 2015-10-29 Gendiag Exe Sl Snps associados a doença tromboembólica
AR101185A1 (es) * 2014-07-11 2016-11-30 Novo Nordiks As Anticuerpos anti-factor v o factor v activado

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049491A (en) * 1987-11-19 1991-09-17 The University Of Vermont Immunologic detection of factor V(VA) fragments in hemorrhagic and thrombotic clinical settings
US5051357A (en) * 1989-07-14 1991-09-24 Board Of Trustees Operating Michigan State University Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor
ES2081618T5 (es) * 1991-11-13 2005-09-01 T.A.C. Thrombosis And Coagulation Aktiebolag Metodo para diagnosticar anomalias de la coagulacion de la sangre.
SE470274B (sv) * 1991-11-13 1993-12-20 Bjoern Dahlbaeck Användning av en in vitro-metod för diagnos av blodkoagulationssjukdomar
PL181102B1 (pl) 1993-01-29 2001-05-31 Dahlbaeck Bjoern Sposób oznaczania w próbce funkcjonalnej aktywności wybranego składnika koagulacji krwi
US5922855A (en) * 1993-12-17 1999-07-13 Oregon Health Sciences University Mammalian DNA mismatch repair genes MLH1 and PMS1
AU697205B2 (en) 1994-04-22 1998-10-01 Stichting Centraal Laboratorium Van De Bloedtransfusiedienst Van Het Nederlandse Rode Kruis Method and means for detecting and treating disorders in the blood coagulation cascade
US5639726A (en) * 1994-09-30 1997-06-17 The Regents Of The University Of Michigan Peptide mediated enhancement of thrombolysis methods and compositions
ATE198772T1 (de) * 1994-11-10 2001-02-15 Dade Behring Marburg Gmbh Verfahren zum spezifischen nachweis eines aktivierten gerinnungsfaktors v mit einer erhöhten stabilität gegenüber aktiviertem protein c
US5705395A (en) 1994-11-14 1998-01-06 The Scripps Research Institute Method for diagnosis of thrombotic disorders
WO1996030546A1 (en) 1995-03-24 1996-10-03 The Scripps Research Institute Methods for identifying a factor v gene mutation
US5874256A (en) * 1995-06-06 1999-02-23 Rijks Universiteit Leiden Method for diagnosing an increased risk for thrombosis or a genetic defect causing thrombosis and kit for use with the same
US5863896A (en) * 1995-11-09 1999-01-26 Immuno Ag Evaluation of substances for altering and for increasing APC response
US5766869A (en) * 1995-11-30 1998-06-16 Ahs Hospital Corp. Factor V ratio blood test for susceptibility to thromboembolism

Also Published As

Publication number Publication date
US6558913B1 (en) 2003-05-06
DE69523179D1 (de) 2001-11-15
CA2159907A1 (en) 1995-08-17
EP0696325A1 (en) 1996-02-14
EP0807691B1 (en) 2001-10-10
US6518016B1 (en) 2003-02-11
DE696325T1 (de) 1996-08-29
ES2166948T3 (es) 2002-05-01
ATE206765T1 (de) 2001-10-15
ES2090001T3 (es) 1998-08-01
JP3163105B2 (ja) 2001-05-08
JPH08509383A (ja) 1996-10-08
KR100384251B1 (ko) 2003-09-19
AU1809195A (en) 1995-08-29
WO1995021938A1 (en) 1995-08-17
DK0807691T3 (da) 2002-02-04
FI954855A0 (fi) 1995-10-12
FI954855A (fi) 1995-11-17
DE69523179T2 (de) 2002-06-06
JP3439458B2 (ja) 2003-08-25
US5910576A (en) 1999-06-08
EP0807691A2 (en) 1997-11-19
EP0696325B1 (en) 1998-05-13
EP0807691A3 (en) 1998-03-11
DK0696325T3 (da) 1999-03-01
GR960300034T1 (en) 1996-06-30
FI117977B (fi) 2007-05-15
DE69502451T2 (de) 1998-09-24
GR3027579T3 (en) 1998-11-30
JP2001242170A (ja) 2001-09-07
DE69502451D1 (de) 1998-06-18
CA2159907C (en) 2006-12-12
ATE166110T1 (de) 1998-05-15
ES2090001T1 (es) 1996-10-16
KR960702007A (ko) 1996-03-28
AU690644B2 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
PT807691E (pt) Metodo para a pesquisa quanto a presenca de um defeito genetico associado a trombose e/ou fraca resposta anticoagulante a proteina c activada
ATE529509T1 (de) Selektion von proteinen unter verwendung von rna- protein-fusionen
DE69832628D1 (de) Rekombinant-kaninchengewebefaktor basiertes prothrombinzeitreagenz
ATE267394T1 (de) Nachweis der krankheitsbedingten konformation eines proteins
DE69434942D1 (de) Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben
ATE237133T1 (de) Assays zur bestimmung von proteinfragmenten in biologischen medien
ATE393228T1 (de) Fusionsproteine und deren verwendung zur messung von protease-aktivität
DE69027431D1 (de) Kumarinderivate zur verwendung als nukleotidvernetzungsreagenzien
DE69435266D1 (de) Methode zur Detektion von Luftblasen
DE69630355D1 (de) Dynamische gerätanpassung unter verwendung von treiber-kandidatlisten
ATE397251T1 (de) Verfahren für das entwerfen von kleinen erythropoietin mimetika
DE3587549D1 (de) Ergänzungstestverfahren von proteine bindenden enzymen.
ATE69108T1 (de) Elektrophoretisches gel hoher aufloesung sowie methode zur abscheidung von serumproteinen.
ATE223491T1 (de) Verfahren zur reinigung von biomolekül- oder proteinkomplexen
DE69728897D1 (de) Saeugetierchemokine
SE9602822D0 (sv) New receptor
WO1998054212A3 (de) Das protein des humanen ryanodinrezeptors vom typ 3 sowie dafür kodierende dna-moleküle
DE69426354D1 (de) Reagenz zur bestimmung von glucose
ATA126996A (de) Vorrichtung zur festlegung von zweischaligen isolierglasscheiben an tragkonstruktionen
DE69000908D1 (de) Leichtes transportables brueckenteil zur ueberwindung von graeben.
SE9604439D0 (sv) New receptor
GB2289125A (en) Methods of assaying data-repairing enzymes and their alkylated derivatives
ATA180596A (de) Vorrichtung zur quantifizierung von prothrombin-derivaten
MX9203296A (es) Proteinas bmp-7.